Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
Eukaryotic protein degradation by the proteasome and the lysosome is a dynamic and complex process in which ubiquitin has a key regulatory role. The distinctive morphology of the postmitotic neuron creates unique challenges for protein degradation systems with respect to cell-surface protein turnover and substrate delivery to proteolytic machineries that are required for both synaptic plasticity and self-renewal. Moreover, the discovery of ubiquitin-positive protein aggregates in a wide spectrum of neurodegenerative diseases underlines the importance and vulnerability of the degradative system in neurons. In this article, we discuss the molecular mechanism of protein degradation in the neuron with respect to both its function and its dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of proteasome activity has been experimentally shown to disrupt synapse composition, promote the aggregation of polyubiquitinated proteins, and ultimately lead to neurodegeneration6.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [6]
In the citing paper
“Effective protein clearance by the proteasome is crucial for various neuronal processes, including synaptic remodeling, cell migration, neurotransmitter release, long-term potentiation, long-term depression, and memory formation5,6.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [6]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840 · cited 1×
“jpg" NDATA ITEM> ]> Eukaryotic cells have evolved complex machineries for protein degradation, and the precise regulation of degradation underlies many fundamental cellular processe”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146 · cited 1×
“Synaptic plasticity and protein turnover As early as 1949, Hebb postulated that “some growth process or metabolic change” may underlie activity-dependent modifications of neuronal connectivit”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“cgi?id=168600">PD ) diseases, are associated with abnormal protein aggregates, implicating degradative dysfunctio”
BackgroundImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Lysosomes: fusion and function
Luzio, J. P., Pryor, P. R., & Bright, N. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2217 · Cited by 1,740 · cited 1×
“2 ) degrades most membrane and endocytosed protein”
BackgroundRecognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716 · cited 1×
“The ubiquitin-chain length was between one and three ubiquitins; K48 chains of four ubiquitins or longer are required for efficient targeting to the proteasom”
BackgroundThe roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · cited 1×
“cgi?id=168600">PD ) diseases, are associated with abnormal protein aggregates, implicating degradative dysfunctio”
BackgroundA proteomics approach to understanding protein ubiquitination
Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D., & Gygi, S. P. (2003) · Nature Biotechnology · doi:10.1038/nbt849 · Cited by 1,602
Research works printed but not linked: 1
- Walkley, S. U. in Neurobiology of Disease (ed. Gilman, S.) 1–18 (Elsevier, Burlington, 2007).
Cited by
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Proteasomal and Autophagic Degradation Systems
Dikic, I. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044908 · Cited by 1,169
Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy
Chan, N. C., Salazar, A. M., Pham, A. H., Sweredoski, M. J., Kolawa, N. J., Graham, R. L. J., Hess, S., & Chan, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr048 · Cited by 993
“In PD and other neurodegenerative disorders—including Alzheimer’s, prion and polyglutamine diseases—defects in the UPS are thought to contribute to toxic accumulation of misfolded or aggregated proteins in the cytosol (14,36).”
BackgroundThe proteasome: overview of structure and functions
TANAKA, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.12 · Cited by 862
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“The UPS becomes activated during OS and works to process misfolded protein-mediating reactions that link abnormal proteins with multiple ubiquitine (Ub) molecules as a signal for degradation domains and may promote their degradation by Ub ligases [137, 138].”
BackgroundInfluentialWu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., Steinberg, J. I., Margittai, M., Kayed, R., Zurzolo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394528 · Cited by 537
Ageing, neurodegeneration and Parkinson's disease
Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430
“There is an age-related decline in activity of proteasomes that degrade damaged or ubiquitinated proteins leading to an increase in abnormal deposition of cellular brain proteins [4].”
BackgroundMitochondria and Neuroplasticity
Cheng, A., Hou, Y., & Mattson, M. P. (2010) · ASN Neuro · doi:10.1042/an20100019 · Cited by 430
“…the pre-and post-synaptic apparatuses for neurotransmission , cytoskeletal remodelling, membrane trafficking, gene transcription, protein synthesis and proteolysis (Shepherd and Huganir, 2007; Bramham, 2008; Greer and Greenberg, 2008; Pak et al., 2008; Tai and Schuman, 2008; Shah et al., 2010).”
BackgroundTai, H.-C., Serrano-Pozo, A., Hashimoto, T., Frosch, M. P., Spires-Jones, T. L., & Hyman, B. T. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.06.033 · Cited by 443
“The primary proteolytic mechanism for both normal and abnormal proteins at the synapse is the UPS.28 To examine whether there is UPS impairment at the synapse in AD, we measured the levels of ubiquitin-protein conjugates (proteasome substrates) in total and synaptic extracts.”
BackgroundSelf-citationUbiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 368
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Thibaudeau, T. A., Anderson, R. T., & Smith, D. M. (2018) · Nature Communications · doi:10.1038/s41467-018-03509-0 · Cited by 360
A Practical Review of Proteasome Pharmacology
Thibaudeau, T. A., & Smith, D. M. (2019) · Pharmacological Reviews · doi:10.1124/pr.117.015370 · Cited by 344
“Maintaining proteostasis in neurons is especially important due to their complex architecture, long lifespan, and inability to dilute aggregate load through cell division (Tai and Schuman, 2008).”
BackgroundThe Role of the Selective Adaptor p62 and Ubiquitin-Like Proteins in Autophagy
Lippai, M., & Lőw, P. (2014) · BioMed Research International · doi:10.1155/2014/832704 · Cited by 322
“The ubiquitin-proteasome pathway plays a crucial role in governing many basic cellular processes, such as normal protein turnover, protein quality control by degrading misfolded and damaged proteins, signal transduction, metabolism, cell death, immune responses, and cell cycle control [4].”
BackgroundTau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system
Lee, M. J., Lee, J. H., & Rubinsztein, D. C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.001 · Cited by 336
The hallmarks of Parkinson's disease
Antony, P. M. A., Diederich, N. J., Krüger, R., & Balling, R. (2013) · The FEBS Journal · doi:10.1111/febs.12335 · Cited by 300
A molecular census of 26 S proteasomes in intact neurons
Asano, S., Fukuda, Y., Beck, F., Aufderheide, A., Förster, F., Danev, R., & Baumeister, W. (2015) · Science · doi:10.1126/science.1261197 · Cited by 311
Lee, J., & Kim, H.-J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.931536 · Cited by 310
“The UPS targets intracellular, soluble, and transmembrane proteins that are extracted from the membrane into the cytosol (Tai and Schuman, 2008).”
BackgroundInfluentialShehata, M., Matsumura, H., Okubo-Suzuki, R., Ohkawa, N., & Inokuchi, K. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4533-11.2012 · Cited by 285
“…via the ubiquitin–proteasome system (Hegde et al., 1993, 1997), which degrades short-lived proteins and is now known as an important modulator of synaptic plasticity, learning and memory, and neurodegeneration (Yao et al., 2007; Yi and Ehlers, 2007; Lee et al., 2008; Tai and Schuman, 2008).”
BackgroundProteostasis, oxidative stress and aging
Korovila, I., Hugo, M., Castro, J. P., Weber, D., Höhn, A., Grune, T., & Jung, T. (2017) · Redox Biology · doi:10.1016/j.redox.2017.07.008 · Cited by 271
Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms
Srivastava, A. K., & Schwartz, C. E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.015 · Cited by 249
“Recently, several studies have highlighted an important function for protein degradation by the ubiquitin proteasome system (UPS) in synaptic plasticity (Mabb and Ehlers, 2010; Segref and Hoppe, 2009; Tai and Schuman, 2008).”
BackgroundIntegrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Fujita, K. A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T. M., Jurkowski, W., Antony, P. M. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8489-4 · Cited by 273
“may directly affect synaptic function and plasticity [66].”
BackgroundDeconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease
Bingol, B., & Sheng, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.11.006 · Cited by 275
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
“Proteins that remain unfolded are degraded not only by the UPS, and the phagosome–lysosome system (Tai and Schuman 2008) or autophagy with three major pathways: chaperone-mediated autophagy (CMA), micro- and macroautophagy (Todde et al. 2009) (Fig.”
BackgroundInfluentialUCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein
Day, I. N. M., & Thompson, R. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.020 · Cited by 263
Ubiquitination in postsynaptic function and plasticity
Mabb, A. M., & Ehlers, M. D. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104129 · Cited by 255
“K63-linked chains, which can scaffold signaling complexes such as the NF-κB signaling pathway, regulate DNA repair, and control endocytosis (Haglund & Dikic 2005).”
InfluentialLoss of Mitochondrial Function Impairs Lysosomes
Demers-Lamarche, J., Guillebaud, G., Tlili, M., Todkar, K., Bélanger, N., Grondin, M., Nguyen, A. P., Michel, J., & Germain, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695825 · Cited by 244
“In some cases, mutations in aggregate-prone proteins ( -synuclein in PD, huntingtin in Huntington disease) cause their accumulation and are directly linked to neuronal loss (1, 2).”
BackgroundLocal and global influences on protein turnover in neurons and glia
Dörrbaum, A. R., Kochen, L., Langer, J. D., & Schuman, E. M. (2018) · eLife · doi:10.7554/elife.34202 · Cited by 249
Self-citationPires, A. O., Mendes-Pinheiro, B., Teixeira, F. G., Anjo, S. I., Ribeiro-Samy, S., Gomes, E. D., Serra, S. C., Silva, N. A., Manadas, B., Sousa, N., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0048 · Cited by 235
“UCHL1 has been shown to be involved in regulation of proteasomal degradation [54], which has been linked with neurodegenerative diseases such as AD and PD [53].”
Wang, W., Zhou, Q., Jiang, T., Li, S., Ye, J., Zheng, J., Wang, X., Liu, Y., Deng, M., Ke, D., et al. (2021) · Theranostics · doi:10.7150/thno.55680 · Cited by 242
“It is well recognized that the proteasome's barrel-like structure does not allow large molecules, such as aggregated tau proteins, to enter directly proteasome was not capable of degrading protein aggregates [30].”
BackgroundRegulated protein turnover: snapshots of the proteasome in action
Bhattacharyya, S., Yu, H., Mim, C., & Matouschek, A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3741 · Cited by 240
Banerjee, S., Neveu, P., & Kosik, K. S. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.023 · Cited by 233
“The ubiquitin-proteasome system (UPS) is an important modulator of several neuronal functions, including growth cone guidance, synapse development, and plasticity (Bingol and Schuman, 2005; DiAntonio et al., 2001; Patrick, 2006; Tai and Schuman, 2008; Yi and Ehlers, 2007).”
Neurotoxicity of methamphetamine: Main effects and mechanisms
Jayanthi, S., Daiwile, A. P., & Cadet, J. L. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113795 · Cited by 220
Ouyang, H., Ali, Y. O., Ravichandran, M., Dong, A., Qiu, W., MacKenzie, F., Dhe-Paganon, S., Arrowsmith, C. H., & Zhai, R. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.273730 · Cited by 221
Tau phosphorylation affects its axonal transport and degradation
Rodríguez-Martín, T., Cuchillo-Ibáñez, I., Noble, W., Nyenya, F., Anderton, B. H., & Hanger, D. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.015 · Cited by 200
“…autophagy and the UPS in neurons has been linked to a number of neurodegenerative disorders characterized by accumulation of misfolded protein aggregates (Bauereis et al., 2011; de Vrij et al., 2004; Li et al., 2010; Martinez-Vicente and Cuervo, 2007; Riederer et al., 2011; Tai and Schuman, 2008).”
BackgroundCui, M., Tang, X., Christian, W. V., Yoon, Y., & Tieu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066662 · Cited by 207
The ubiquitin proteasome system in neuropathology
Lehman, N. L. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0560-x · Cited by 207
“Furthermore, the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/ PDC) shows histopathological overlap with all major types of neurodegeneration further illustrating the central role of the UPS in the pathophysiology of neurodegeneration [91, 122].”
BackgroundFranco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 194
Jarome, T. J., Werner, C. T., Kwapis, J. L., & Helmstetter, F. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024349 · Cited by 183
“transcription, apoptosis and more recently has been implicated in synaptic plasticity [16–20].”
BackgroundA Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
George, A. J., Hoffiz, Y. C., Charles, A. J., Zhu, Y., & Mabb, A. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00029 · Cited by 172
“In the nervous system, E3 ligases are an integral part of the ubiquitin proteasome pathway involved in the turnover of proteins (Tai and Schuman, 2008; Mabb and Ehlers, 2010; Yamada et al., 2013).”
BackgroundBanerjee, S., Ji, C., Mayfield, J. E., Goel, A., Xiao, J., Dixon, J. E., & Guo, X. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806797115 · Cited by 174
Molecular mechanism of curcumin action in signaling pathways: Review of the latest research
Liczbiński, P., Michałowicz, J., & Bukowska, B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6663 · Cited by 168
Protein-Thiol Oxidation and Cell Death: Regulatory Role of Glutaredoxins
Allen, E. M. G., & Mieyal, J. J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4644 · Cited by 171
“A disruption in mitochondrial function is also common in diseases of the elderly, causing the accumulation of ROS, coupled with decreases in the antioxidant defenses of the cell (4, 13, 21, 22, 40, 44, 64, 68, 70, 103).”
Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.
Guo, X., Wang, X., Wang, Z., Banerjee, S., Yang, J., Huang, L., & Dixon, J. E. (2016) · Nature Cell Biology · doi:10.1038/ncb3289 · Cited by 169
“This perception has drastically changed with recent studies showing that proteasome activity and abundance are dynamically regulated under physiological and pathological conditions 2-4, 38 .”
Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D. S., Ketzef, M., Becker, A. J., Friedman, A., & Soreq, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100995 · Cited by 167
“GO analysis revealed that these alternatively spliced transcripts belong to categories such as regulation of ubiquitin protein-ligase activity (Tai & Schuman, 2008), isomerase activity (Pastorino et al, 2006; Uehara et al, 2006), neuron projections (Luo & O’Leary, 2005) and RNA-binding activity…”
Copper: from neurotransmission to neuroproteostasis
Opazo, C. M., Greenough, M. A., & Bush, A. I. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00143 · Cited by 160
“The UPS is a major pathway by which cells remove normal proteins and abnormally folded normal or mutant, cytoplasmic and membrane proteins (Tai and Schuman, 2008).”
BackgroundActivity-dependent growth of new dendritic spines is regulated by the proteasome
Hamilton, A. M., Oh, W. C., Vega-Ramirez, H., Stein, I. S., Hell, J. W., Patrick, G. N., & Zito, K. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.031 · Cited by 164
“Malfunction of the proteasome (Tai and Schuman, 2008) and alterations in dendritic spine morphologies and densities (Bhatt et al.”
Ramachandran, K. V., & Margolis, S. S. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3389 · Cited by 151
“These end-products of proteotoxic stress are hallmarks of many neurodegenerative disorders 49,50 , a fact which places the NMP at the heart of various disease states.”
Jarome, T. J., & Helmstetter, F. J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.03.009 · Cited by 159
“…& Schuman, 2005; Bingol & Sheng, 2011; Fioravante & Byrne, 2011; Geng, Wenzel, & Tansey, 2012; Hegde, 2010; Mabb & Ehlers, 2010; Patrick, 2006; Tai & Schuman, 2008; Yi & Ehlers, 2005), but generally proteins become targeted for degradation through the coordinated actions of many different…”
Yin, X., Takei, Y., Kido, M. A., & Hirokawa, N. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.049 · Cited by 150
“Ubiquitin targets many neuronal proteins for degradation by the proteasome or lysosome complexes and thereby participates in the regulation of synaptic function (Tai and Schuman, 2008; Yi and Ehlers, 2007).”
Arloth, J., Bogdan, R., Weber, P., Frishman, G., Menke, A., Wagner, K. V., Balsevich, G., Schmidt, M. V., Karbalai, N., Czamara, D., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.034 · Cited by 142
Characterization of the brain 26S proteasome and its interacting proteins
Tai, H., Besche, H., Goldberg, A. L., & Schuman, E. M. (2010) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2010.00012 · Cited by 145
“Our data suggests that the interaction may be partially mediated by drebrin, an important actin-binding protein in the spine (Takahashi et al., 2009).”
Self-citationStress-induced metaplasticity: From synapses to behavior
Schmidt, M. V., Abraham, W. C., Maroun, M., Stork, O., & Richter‐Levin, G. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.059 · Cited by 146
Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
van Eersel, J., Ke, Y. D., Gladbach, A., Bi, M., Götz, J., Kril, J. J., & Ittner, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022850 · Cited by 130
“Proteasome dysfunction has been implicated in several neurodegenerative disorders, including ALS [43,46].”
BackgroundInfluentialKiely, A. P., Ling, H., Asi, Y. T., Kara, E., Proukakis, C., Schapira, A. H. V., Morris, H. R., Roberts, H. C., Lubbe, S. J., Limousin, P. D., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0038-3 · Cited by 135
“Ubiquitin is a small molecule which can become covalently bound to proteins in an event called ubiquitination which is believed to signal for degradation of that protein via the ubiquitin-proteosomal system [19].”
BackgroundSynaptic Protein Ubiquitination in Rat Brain Revealed by Antibody-based Ubiquitome Analysis
Na, C. H., Jones, D. R., Yang, Y., Wang, X., Xu, Y., & Peng, J. (2012) · Journal of Proteome Research · doi:10.1021/pr300536k · Cited by 139
Hemoglobin-derived Peptides as Novel Type of Bioactive Signaling Molecules
Gomes, I., Dale, C. S., Casten, K., Geigner, M. A., Gozzo, F. C., Ferro, E. S., Heimann, A. S., & Devi, L. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9217-x · Cited by 123
“The proteasome is a large proteolytic complex ubiquitously distributed among mammalian cells including neuronal cells ( 87 ).”
BackgroundThe role of ubiquitylation in nerve cell development
Kawabe, H., & Brose, N. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3009 · Cited by 133
“Since then, the analysis of ubiquitylation in the developing and mature brain has become a major new focus in neuroscience, not least because ubiquitylation seems to play a key part in neurodegenerative disorder”
BackgroundThe ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
Gadhave, K., Bolshette, N. B., Ahire, A., Pardeshi, R., Thakur, K. K., Trandafir, C.-M., Istrate, A., Ahmed, S., Lahkar, M., Muresanu, D. F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12817 · Cited by 130
“The UPS includes five steps: activation, conjugation, recognition, ubiquitin removal by specific deubiquitinating enzymes (DUBs) and substrate degradation by the proteasome [16, 17].”
BackgroundTundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 125
A Conserved F Box Regulatory Complex Controls Proteasome Activity in Drosophila
Bader, M., Benjamin, S., Wapinski, O. L., Smith, D. M., Goldberg, A. L., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.03.021 · Cited by 117
“Neuronal remodeling is important for normal development, but has also been implicated in neurodegenerative diseases (Nikolaev et al., 2009; Raff et al., 2002; Tai and Schuman, 2008).”
Nakagawa, T., & Xiong, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.033 · Cited by 116
“Disruption of this system has been linked to the development of various types of human diseases, including autoimmunity (Bhoj and Chen, 2009), neurological diseases (Tai and Schuman, 2008; Yi and Ehlers, 2007), and cancer (Frescas and Pagano, 2008; Nakayama and Nakayama, 2006).”
Emerging Paradigm of Crosstalk between Autophagy and the Ubiquitin-Proteasome System.
Nam, T., Han, J. H., Devkota, S., & Lee, H. (2017) · PubMed Central · doi:10.14348/molcells.2017.0226 · Cited by 126
“One of the most crucial molecules that marks target proteins for degradation in both these pathways is ubiquitin (Tai and Schuman, 2008).”
BackgroundStructure, Dynamics and Function of the 26S Proteasome
Mao, Y. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-58971-4_1 · Cited by 121
Spangler, S. A., Schmitz, S. K., Kevenaar, J. T., de Graaff, E., de Wit, H., Demmers, J., Toonen, R. F. G., & Hoogenraad, C. C. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201301011 · Cited by 111
“Because the ubiquitin–proteasome system plays an important role in synaptic protein turnover (Tai and Schuman, 2008; Bingol and Sheng, 2011), we tested whether the proteasome inhibitor MG132 affects liprin-2 expression in hippocampal neurons.”
Küry, S., Besnard, T., Ebstein, F., Khan, T. N., Gambin, T., Douglas, J., Bacino, C. A., Craigen, W. J., Sanders, S. J., Lehmann, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.003 · Cited by 110
Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis
Hamilton, A. M., & Zito, K. (2013) · Neural Plasticity · doi:10.1155/2013/196848 · Cited by 110
“A number of neurological disorders have been associated with reduced proteasome activity and the consequent buildup of ubiquitinated proteins, including Alzheimer’s, Huntington’s, and Parkinson’s [6].”
Garbes, L., Rießland, M., Hölker, I., Heller, R., Hauke, J., Tränkle, C., Coras, R., Blümcke, I., Hahnen, E., & Wirth, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp313 · Cited by 110
Franco, M., Seyfried, N. T., Brand, A. H., Peng, J., & Mayor, U. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002188 · Cited by 109
Regulation of Protein Degradation by Proteasomes in Cancer
Jang, H. H. (2018) · Journal of Cancer Prevention · doi:10.15430/jcp.2018.23.4.153 · Cited by 112
“Through this, it intervenes in not only protein degradation but also immune response and DNA repair.(38,39)”
BackgroundMutations in a BTB-Kelch Protein, KLHL7, Cause Autosomal-Dominant Retinitis Pigmentosa
Friedman, J. S., Ray, J. W., Waseem, N. H., Johnson, K. R., Brooks, M. J., Hugosson, T., Breuer, D. K., Branham, K. E. H., Krauth, D. S., Bowne, S. J., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.05.007 · Cited by 104
“The significance of protein-degradation pathways in neuronal development and function is underscored by the fact that protein aggregates are hallmarks of several neurodegenerative diseases.(42,43) Notably, mutations in another BTB-Kelch protein family member, gigaxonin (GAN [MIM 605379]), are responsible for giant axo…”
BackgroundThe proteasome and its role in the nervous system
Türker, F., Cook, E. K., & Margolis, S. S. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.003 · Cited by 106
Bustamante, H. A., González, A., Cerda‐Troncoso, C., Shaughnessy, R., Otth, C., Soza, A., & Burgos, P. V. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00126 · Cited by 107
“The UPS regulates several aspects of brain function including synaptic plasticity, growth and development of immature neurons (Yi and Ehlers, 2007), and the abundance of proteins in the postsynaptic density involved in the postsynaptic response (Ehlers, 2003; Bingol and Schuman, 2004; Tai and Schuman, 2008).”
BackgroundHans, F., Fiesel, F. C., Strong, J. C., Jäckel, S., Rasse, T. M., Geisler, S., Springer, W., Schulz, J. B., Voigt, A., & Kahle, P. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561704 · Cited by 103
“This is the main catabolic pathway of short lived proteins and provides a defense system against misfolded and aggregating proteins such as those that occur during aging and particularly in patients with neurodegenerative proteinopathies (62).”
BackgroundShin, W. H., Park, J. H., & Chung, K. C. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.283 · Cited by 104
“that marks the target for degradation via both pathways is the ubiquitin (13).”
BackgroundLi, Y., Guo, Y., Wang, X., Yu, X., Duan, W., Hong, K., Wang, J., Han, H., & Li, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.061 · Cited by 97
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 106
Basel‐Vanagaite, L., Dallapiccola, B., Ramírez‐Solis, R., Segref, A., Thiele, H., Edwards, A., Arends, M. J., Miró, X., White, J. K., Désir, J., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.10.011 · Cited by 106
“Consequently, alterations of the UPS can engender neuronal dysfunction and lead to neurological disease and intellectual disability (ID).(2) A prototype disorder involving altered ubiquitination is the human neurodevelopmental disease Angelman syndrome (MIM 105830).”
Proteome dynamics during homeostatic scaling in cultured neurons
Dörrbaum, A. R., Alvarez‐Castelao, B., Nassim-Assir, B., Langer, J. D., & Schuman, E. M. (2020) · eLife · doi:10.7554/elife.52939 · Cited by 105
Self-citationJerath, N. U., & Shy, M. E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.031 · Cited by 96
Presynaptic function in health and disease
Waites, C. L., & Garner, C. C. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.03.004 · Cited by 106
A large dataset of protein dynamics in the mammalian heart proteome
Lau, E., Cao, Q., Ng, D. C. M., Bleakley, B. J., Dincer, T. U., Bot, B. M., Wang, D., Liem, D. A., Lam, M. P. Y., Ge, J., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.15 · Cited by 96
In vivo monitoring of tissue regeneration using a ratiometric lysosomal AIE probe
Shi, X., Yan, N., Niu, G., Sung, S. H. P., Liu, Z., Liu, J., Kwok, R. T. K., Lam, J. W. Y., Wang, W., Sung, H. H. Y., et al. (2020) · Chemical Science · doi:10.1039/c9sc06226b · Cited by 90
Protein degradation on the global scale
Rusilowicz-Jones, E. V., Urbé, S., & Clague, M. J. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.027 · Cited by 89
Defective proteostasis in Alzheimer’s disease
Cozachenco, D., Ribeiro, F. C., & Ferreira, S. T. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101862 · Cited by 92
Direct cellular delivery of human proteasomes to delay tau aggregation
Han, D. H., Na, H.-K., Choi, W. H., Lee, J. H., Kim, Y. K., Won, C., Lee, S.-H., Kim, K. P., Kuret, J., Min, D.-H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6633 · Cited by 88
Richman, S. A., Wang, L.-C., Moon, E. K., Khire, U. R., Albelda, S. Μ., & Milone, M. C. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.004 · Cited by 91
Ubiquitin, Autophagy and Neurodegenerative Diseases
Watanabe, Y., Taguchi, K., & Tanaka, M. (2020) · Cells · doi:10.3390/cells9092022 · Cited by 91
“and two regulatory complexes (19S and 11S) [65].”
BackgroundCopping, N. A., Christian, S., Ritter, D., Islam, M. S., Buscher, N., Żółkowska, D., Pride, M. C., Berg, E. L., LaSalle, J. M., Ellegood, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx289 · Cited by 95
Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGFβ-Mediated Axonogenesis
Stegeman, S., Jolly, L. A., Premarathne, S., Gécz, J., Richards, L. J., Mackay‐Sim, A., & Wood, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068287 · Cited by 90
“The ubiquitin system regulates protein stability, localisation and function in a rapid and quantitative manner and has been shown to regulate multiple aspects of neural development [1] [2] [3] [4].”
E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration
Upadhyay, A., Joshi, V., Amanullah, A., Mishra, R., Arora, N., Prasad, A., & Mishra, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00151 · Cited by 87
“…many years, indispensable roles of E3 ubiquitin ligases in proteasome-mediated proteolysis of crucial substrate proteins, which play important roles in several pathways of neuronal development, have been investigated in detail (Segref and Hoppe, 2008; Tai and Schuman, 2008; Yamada et al., 2013).”
BackgroundInfluentialOxygen-Dependent Cleavage of the p75 Neurotrophin Receptor Triggers Stabilization of HIF-1α
Moan, N. L., Houslay, D. M., Frank, C., Houslay, M. D., & Akassoglou, K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.033 · Cited by 89
“Thus, defects in protein degradation may lead to severe pathogenic disorders like neurodegeneration and cancer (Hoeller et al., 2006; Tai and Schuman, 2008).”
Aaptamine, an alkaloid from the sponge Aaptos suberitoides, functions as a proteasome inhibitor
Tsukamoto, S., Yamanokuchi, R., Yoshitomi, M., Sato, K., Ikeda, T., Rotinsulu, H., Mangindaan, R. E. P., de Voogd, N. J., van Soest, R. W. M., & Yokosawa, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.029 · Cited by 78
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
Sherman, D. J., & Li, J. (2020) · Molecules · doi:10.3390/molecules25030671 · Cited by 84
Protein degradation and memory formation
Fioravante, D., & Byrne, J. H. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.11.002 · Cited by 85
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2
Gorrie, G., Fecto, F., Radzicki, D., Weiss, C., Shi, Y., Dong, H., Zhai, H., Fu, R., Liu, E., Li, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405741111 · Cited by 81
“Our data suggest a unifying hypothesis of interplay between aggregate formation and UPS failure in close proximity to synapses.”
BackgroundInfluentialYan, J. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2300 · Cited by 79
“Finally, ubiquitinated proteins are deubiquitinated by deubiqutinase (DUB) and unfolded by unfoldase before entering the proteolytic lumen of 26S proteasome (Tai and Schuman, 2008).”
Roles of trinucleotide-repeat RNA in neurological disease and degeneration
Li, L., & Bonini, N. M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.03.004 · Cited by 83
Mechanistic advances in axon pathfinding
McCormick, L. E., & Gupton, S. L. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.12.003 · Cited by 81
Unraveling the Complexity of Ubiquitin Signaling
Strieter, E. R., & Korasick, D. A. (2011) · ACS Chemical Biology · doi:10.1021/cb2004059 · Cited by 87
Kyöstilä, K., Čižinauskas, S., Seppälä, E. H., Suhonen, E., Jeserevics, J., Sukura, A., Syrjä, P., & Lohi, H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002759 · Cited by 79
“Impaired protein degradation is a common feature in several neurodegenerative diseases [42,43].”
Background
Metadata
- Authors
- Tai, H.-C., & Schuman, E. M.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Schuman, Erin M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2008-11
- Volume
- 9
- Issue
- 11
- Pages
- 826-838
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2060776482
- Cited by
- 532
- References
- 148
- Citations by year
- 2026: 18 · 2025: 34 · 2024: 36 · 2023: 28 · 2022: 28 · 2021: 35 · 2020: 32 · 2019: 25 · 2018: 28 · 2017: 36 · 2016: 27 · 2015: 21 · 2014: 32 · 2013: 29 · 2012: 33
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- ubiquitin, proteasome, protein degradation, neurons, neurodegenerative diseases, lysosomes, postmitotic neurons, synaptic plasticity, protein aggregates, substrate supply
- MeSH terms
- Animals, Humans, Neurons, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.